ARTICLE | Clinical News
MG98: Phase II start
October 11, 2004 7:00 AM UTC
MYG began a 2-step Phase II trial of MG98 plus interferon alpha. The first step will evaluate the safety, pharmacokinetics and optimal dosing of the combination therapy in 30-50 chemotherapy-naive pat...